OBJECTIVES: To analyze antipsychotic prescribing patterns in a UK high security hospital (HSH) that treats seriously violent @entity1 with either @entity161 or @entity1314 and examine how different groups consented to treatment and prescribing for metabolic conditions. We hypothesized that there would be high prevalence of antipsychotic polypharmacy, and high-dose antipsychotic and @entity1088 prescribing. BACKGROUND: HSHs treat seriously violent, mentally disordered offenders, and the extant literature on prescribing patterns in forensic settings is sparse. METHODS: Prescribing and clinical data on all 189 @entity1 in a UK HSH were collected from the hospital's databases. Data were analyzed using SPSS. RESULTS: The population was split into the following groups: @entity161 spectrum disorder (SSD-only), @entity1314 ( @entity1726 ), and comorbid @entity161 spectrum @entity1726 . The majority (93.7%) of all @entity1 were prescribed at least one antipsychotic, and (27.5%) were on @entity1088 . Polypharmacy was prevalent in 22.2% and high-dose antipsychotic in 27.5%. @entity1 on @entity1088 were more likely to be prescribed antidiabetic, statins, or antihypertensive medication. @entity1 in the @entity1726 group were more likely to be deemed to have the capacity to consent to treatment and be prescribed @entity1088 in contrast to the SSD-only group. CONCLUSIONS: Rates of @entity1088 and high-dose antipsychotic prescribing were higher than in other @entity146 settings, while polypharmacy prescribing rates were lower. Higher @entity1088 prescribing rates may be a function of a treatment-resistant and aggressive population. A higher proportion of @entity1726 @entity1 consented to treatment and received @entity1088 compared with in-house SSD-only as well as other @entity146 settings. Implications of the findings are discussed.

Psychotropic prescribing in seriously violent @entity1 with XXXX or @entity1314 in a UK high security hospital.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'men'] @entity1088 :: ('MESH:D003024', 'Chemical') :: ['clozapine'] @entity146 :: ('MESH:D001523', 'Disease') :: ['psychiatric'] @entity1726 :: ('OMIM:168600', 'Disease') :: ['PD-only', 'disorder and PD'] @entity161 :: ('MESH:D012559', 'Disease') :: ['schizophrenia'] @entity1314 :: ('MESH:D010554', 'Disease') :: ['personality disorder']
@entity161 :: (MESH:D012559,Disease) :: ['schizophrenia']
